Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve?

Kohan DE, Cleland JG, Rubin LJ, Theodorescu D, Barton M.

Life Sci. 2012 Oct 15;91(13-14):528-39. doi: 10.1016/j.lfs.2012.07.034. Epub 2012 Aug 6. Review.

PMID:
22967485
[PubMed - indexed for MEDLINE]
Free Article
2.

Endothelin antagonists in clinical trials: lessons learned.

Barton M, Kohan DE.

Contrib Nephrol. 2011;172:255-60. doi: 10.1159/000328859. Epub 2011 Aug 30.

PMID:
21894005
[PubMed - indexed for MEDLINE]
3.

The Twelfth International Conference on Endothelin (ET-12), Cambridge 2011.

Barton M, Davenport AP.

Life Sci. 2012 Oct 15;91(13-14):462-5. doi: 10.1016/j.lfs.2012.07.015. Epub 2012 Jul 26.

PMID:
22842028
[PubMed - indexed for MEDLINE]
Free Article
4.

Endothelin receptor antagonists.

Motte S, McEntee K, Naeije R.

Pharmacol Ther. 2006 Jun;110(3):386-414. Epub 2005 Oct 10. Review.

PMID:
16219361
[PubMed - indexed for MEDLINE]
5.

Endothelin receptor antagonists for pulmonary arterial hypertension.

Liu C, Cheng J.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004434. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD004434.

PMID:
15674947
[PubMed - indexed for MEDLINE]
6.

Endothelin receptor antagonists: current status and perspectives.

Clozel M.

J Cardiovasc Pharmacol. 2000;35(4 Suppl 2):S65-68. Review.

PMID:
10976785
[PubMed - indexed for MEDLINE]
7.

Endothelin receptor antagonists for pulmonary arterial hypertension.

Liu C, Chen J.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004434. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD004434.

PMID:
16856046
[PubMed - indexed for MEDLINE]
8.

Endothelin receptor antagonists for the treatment of pulmonary artery hypertension.

Rubin LJ.

Life Sci. 2012 Oct 15;91(13-14):517-21. doi: 10.1016/j.lfs.2012.07.033. Epub 2012 Aug 3. Review.

PMID:
22884806
[PubMed - indexed for MEDLINE]
Free Article
9.

Endothelin in health and disease: endothelin receptor antagonists in the management of pulmonary artery hypertension.

Kim NH, Rubin LJ.

J Cardiovasc Pharmacol Ther. 2002 Jan;7(1):9-19. Review.

PMID:
12000973
[PubMed - indexed for MEDLINE]
10.

Endothelin receptor antagonists for pulmonary arterial hypertension.

Liu C, Chen J, Gao Y, Deng B, Liu K.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD004434. doi: 10.1002/14651858.CD004434.pub5. Review.

PMID:
23450552
[PubMed - indexed for MEDLINE]
11.

Endothelin receptor antagonists in pulmonary arterial hypertension.

Channick RN, Sitbon O, Barst RJ, Manes A, Rubin LJ.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):62S-67S. Review.

PMID:
15194180
[PubMed - indexed for MEDLINE]
12.

Endothelin receptor antagonism: role in the treatment of pulmonary arterial hypertension related to scleroderma.

Kabunga P, Coghlan G.

Drugs. 2008;68(12):1635-45. Review.

PMID:
18681488
[PubMed - indexed for MEDLINE]
13.

Endothelin receptor antagonists for pulmonary arterial hypertension.

Liu C, Chen J, Gao Y, Deng B, Liu K.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004434. doi: 10.1002/14651858.CD004434.pub4. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD004434.

PMID:
19588356
[PubMed - indexed for MEDLINE]
14.

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension.

Steiner MK, Preston IR.

Vasc Health Risk Manag. 2008;4(5):943-52. Review.

PMID:
19183742
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials.

Aubert JD, Juillerat-Jeanneret L.

Expert Opin Ther Targets. 2009 Sep;13(9):1069-84. doi: 10.1517/14728220903074570. Review.

PMID:
19659448
[PubMed - indexed for MEDLINE]
16.

Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases.

Humbert M, Simonneau G.

Nat Clin Pract Rheumatol. 2005 Dec;1(2):93-101. Review.

PMID:
16932638
[PubMed - indexed for MEDLINE]
17.

Endothelin receptor antagonists -- their role in pulmonary medicine.

Boniface S, Reynaud-Gaubert M.

Rev Mal Respir. 2011 Oct;28(8):e94-e107. doi: 10.1016/j.rmr.2009.07.001. Epub 2011 Oct 27. Review.

PMID:
22099418
[PubMed - indexed for MEDLINE]
18.

Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug.

Battistini B, Berthiaume N, Kelland NF, Webb DJ, Kohan DE.

Exp Biol Med (Maywood). 2006 Jun;231(6):653-95. Review.

PMID:
16740981
[PubMed - indexed for MEDLINE]
19.

Current status of endothelin blockade for the treatment of cardiovascular and pulmonary vascular disease.

Krum H, Liew D.

Curr Opin Investig Drugs. 2003 Mar;4(3):298-302. Review.

PMID:
12744222
[PubMed - indexed for MEDLINE]
20.

Endothelin XII.

Barton M, Yanagisawa M, Vanhoutte PM, Masaki T.

Life Sci. 2012 Oct 15;91(13-14):449-51. doi: 10.1016/j.lfs.2012.07.016. Epub 2012 Jul 26.

PMID:
22842029
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk